Atlas Trials

Mitochondrial Network Modulation Approach Using Hyperbaric Oxygen (HBO) Therapy and Nb-UVB for Treating Vitiligo

Clinical trial NCT07557693 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07557693
Sponsor
Centre Hospitalier Universitaire de Nice
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Vitiligo Vulgaris
Start date
2026-09-01
Primary completion
2027-09-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.